Jim Simons Edesa Biotech, Inc. Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.91 - $2.63 $15,926 - $46,030	17,502 New	17,502 $16,000
Q2 2022 Aug 12, 2022	SELL	$1.47 - $2.94 $53,731 - $107,462	-36,552 Reduced 44.14%	46,248 $74,000
Q1 2022 May 13, 2022	BUY	$2.72 - $5.97 $135,184 - $296,709	49,700 Added 150.15%	82,800 $246,000
Q4 2021 Feb 11, 2022	BUY	$5.17 - $8.65 $171,127 - $286,315	33,100 New	33,100 $186,000
Q1 2021 May 13, 2021	SELL	$4.3 - $7.48 $318,630 - $554,268	-74,100 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$4.25 - $8.14 $314,925 - $603,174	74,100 New	74,100 $315,000
Q1 2020 May 14, 2020	SELL	$1.64 - $4.09 $41,119 - $102,548	-25,073 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$3.94 - $6.42 $36,720 - $59,834	9,320 Added 59.16%	25,073 $103,000
Q3 2019 Nov 13, 2019	SELL	$3.39 - $7.52 $19,258 - $42,721	-5,681 Reduced 26.5%	15,753 $98,000
Q2 2019 Aug 12, 2019	BUY	$3.82 - $11.7 $81,877 - $250,777	21,434 New	21,434 $151,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $38.2M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.